XML 32 R5.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Revenues $ 13,951.7 $ 13,008.9 $ 12,161.6
Cost of revenues 9,939.2 9,384.5 8,796.7
Gross profit 4,012.5 3,624.4 3,364.9
Selling, general, and administrative expenses 2,216.3 2,230.0 2,021.4
Amortization of intangibles and other assets 280.0 256.4 219.8
Asset Impairment Charges 4.3 5.3 349.0
Restructuring and other charges 127.2 46.0 49.1
Operating income 1,384.7 1,086.7 725.6
Interest expense (224.1) (208.3) (199.6)
Investment income 15.2 22.3 28.8
Equity method loss, net (13.3) (1.4) (1.4)
Other, net (55.0) 60.2 15.5
Earnings from continuing operations before income taxes 1,107.5 959.5 568.9
Provision for income taxes 229.8 212.4 188.5
Earnings from continuing operations 877.7 747.1 380.4
Earnings from discontinued operations, net of tax 0.0 0.0 38.8
Net earnings 877.7 747.1 419.2
Less: Net earnings attributable to the noncontrolling interest (1.2) (1.1) (1.2)
Net earnings attributable to Labcorp Holdings Inc. $ 876.5 $ 746.0 $ 418.0
Basic earnings per share from continuing operations $ 10.54 $ 8.89 $ 4.35
Basic earnings per share from discontinued operations 0 0 0.45
Basic earnings per share 10.54 8.89 4.80
Diluted earnings per share from continuing operations 10.46 8.84 4.33
Diluted earnings per share from discontinued operations 0 0 0.44
Diluted earnings per share $ 10.46 $ 8.84 $ 4.77